SELGIA Trademark

Trademark Overview

On Thursday, October 22, 2009, a trademark application was filed for SELGIA with the United States Patent and Trademark Office. The USPTO has given the SELGIA trademark a serial number of 77855192. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 6, 2014. This trademark is owned by Glaxo Group Limited. The SELGIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for human use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for human use for the treatment of damaged skin and tissue; vaccines for human use
selgia

General Information

Serial Number77855192
Word MarkSELGIA
Filing DateThursday, October 22, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 6, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for human use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for human use for the treatment of damaged skin and tissue; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB

Trademark Events

Event DateEvent Description
Monday, January 6, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 6, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2013EXTENSION 5 GRANTED
Thursday, April 18, 2013EXTENSION 5 FILED
Thursday, April 18, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 19, 2012EXTENSION 4 GRANTED
Friday, November 16, 2012EXTENSION 4 FILED
Friday, November 16, 2012TEAS EXTENSION RECEIVED
Friday, May 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 17, 2012EXTENSION 3 GRANTED
Monday, May 14, 2012EXTENSION 3 FILED
Monday, May 14, 2012TEAS EXTENSION RECEIVED
Tuesday, November 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2011EXTENSION 2 GRANTED
Friday, November 4, 2011EXTENSION 2 FILED
Friday, November 4, 2011TEAS EXTENSION RECEIVED
Saturday, April 23, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 22, 2011EXTENSION 1 GRANTED
Wednesday, April 20, 2011EXTENSION 1 FILED
Friday, April 22, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 20, 2011TEAS EXTENSION RECEIVED
Tuesday, November 30, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 5, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2010PUBLISHED FOR OPPOSITION
Wednesday, September 1, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 1, 2010ASSIGNED TO LIE
Thursday, August 19, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 28, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 28, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 28, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 28, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 28, 2010NON-FINAL ACTION E-MAILED
Thursday, January 28, 2010NON-FINAL ACTION WRITTEN
Wednesday, January 27, 2010ASSIGNED TO EXAMINER
Tuesday, October 27, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 26, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

selgia treatment pharmaceutical human substances preparations disorders diseases gastrointestinal hormonal respiratory